Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Fay J. Hlubocky, PhD, MA

Advertisement

Articles by Fay J. Hlubocky, PhD, MA

Fay J. Hlubocky on Concerns About Death in Young Survivors

ByFay J. Hlubocky, PhD, MA
August 25th 2016

Fay J. Hlubocky, PhD, MA, University of Chicago Department of Medicine, discusses the concerns about death that young adult survivors face.

Fay J. Hlubocky on Addressing Issues of Young Cancer Survivors

ByFay J. Hlubocky, PhD, MA
June 14th 2016
Advertisement

Latest Updated Articles

  • Fay J. Hlubocky on Addressing Issues of Young Cancer Survivors
    Fay J. Hlubocky on Addressing Issues of Young Cancer Survivors

    June 14th 2016

  • Fay J. Hlubocky on Concerns About Death in Young Survivors
    Fay J. Hlubocky on Concerns About Death in Young Survivors

    August 25th 2016



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Camizestrant Approval: Nurses Key to New Breast Cancer Paradigm

2

FDA Approves Iberdomide: A New Oral Paradigm in Multiple Myeloma Care

3

Nursing Protocols for the New Oral RAS Inhibitor Daraxonrasib

4

FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer

5

How the Emerging MPN Pipeline Will Reshape PV Nursing and Patient Care

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us